Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda
Willy Ssengooba(Makerere University), Moses Joloba(Ministry of Health), Harriet Mayanja‐Kizza(Makerere University), Gerald Mboowa(African Union Commission), Carolyn Namaganda(Makerere University), Anne Wajja(Infectious Diseases Institute), Philippa Musoke(Centers for Disease Control and Prevention), Sebastian Gelderbloem(Aeras)
Cited by 23
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus
|PLoS Biology|2022|350
Novel serologic biomarkers provide accurate estimates of recent <i>Plasmodium falciparum</i> exposure for individuals and communities
|Proceedings of the National Academy of Sciences|2015|219